As of Jul 02
| -0.21 / -3.63%|
The 6 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 12.50, with a high estimate of 19.00 and a low estimate of 8.50. The median estimate represents a +124.01% increase from the last price of 5.58.
The current consensus among 6 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.